65th Annual Meeting of the German Society of Neurosurgery (DGNC)
German Society of Neurosurgery (DGNC)
11 - 14 May 2014, Dresden
Lectures Wednesday, May 14 2014
MI.17 Brain Tumors – Clinical Investigations 2
Meeting Abstract
(MI.17.01)
[Full Text]
Feasibility of fluorescence-guided resection of recurrent gliomas using Five-Aminolevulinic Acid – Retrospective analysis of surgical and neurological outcome in 47 patients
Hickmann AK, Nadji-Ohl M, Bittl M, Hopf NJ[Full Text]
Meeting Abstract
(MI.17.02)
[Full Text]
Impaired cerebrospinal fluid circulation in cerebral glioma – identification of risk factors and evaluation of treatment options
Beez T, Burgula S, Rapp M, Steiger HJ, Sabel M[Full Text]
Meeting Abstract
(MI.17.03)
[Full Text]
Outcome and prognostic factors of patients with secondary glioblastoma
Zappi J, Geßler F, Mittelbronn M, Franz K, Seifert V, Senft C[Full Text]
Meeting Abstract
(MI.17.04)
[Full Text]
Beneficial prognostic value of younger age in adults with glioblastomas; treatment bias or different biology?
Gousias K, Gielen GH, Oszvald A, Waha A, Vatter H, Güresir E[Full Text]
Meeting Abstract
(MI.17.05)
[Full Text]
Bevacizumab monotherapy in recurrent glioblastoma: “off label use” in cases of salvage therapy
Richter C, Keric N, Renovanz M, Giese A[Full Text]
Meeting Abstract
(MI.17.06)
[Full Text]
Recurrent glioblastoma multiforme: the role of combined salvage therapies and introduction of a new treatment algorithm
Archavlis E, Tselis N, Birn G, Ulrich P, Zamboglou N[Full Text]
Meeting Abstract
(MI.17.07)
[Full Text]
Brain metastases from NSCLC: A mono-institutional restrospective analysis
Enders F, von Deimling A, Herold-Mende C, Unterberg A[Full Text]
Meeting Abstract
(MI.17.08)
[Full Text]
Increased expression of the oncotarget Eag1 in brain metastasis compared to their corresponding primary carcinomas
Martinez R, Rohde V, Reichmann A, Martin S, Pardo L[Full Text]
Meeting Abstract
(MI.17.09)
[Full Text]
Salvage treatment of small sized recurrent metastasis with stereotactic Iodine-125 brachytherapy: a risk-benefit analysis
Romagna A, Schwartz C, Tonn JC, Nachbichler S, Kreth FW[Full Text]
